New drug access for patients in need
NCT ID NCT06994117
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This program offers expanded access to mezigdomide for eligible participants who have no other treatment options. The goal is to provide this medication to those who may benefit from it. Participants must meet specific criteria to join.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new related studies are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact